New Report
Biotechnology and Pharmaceuticals Report
November 14, 2011
5 leading Analysts; and top management from 4 Sector Firms examine this vital industry
» See all the topics and companies covered
-
Orphan Drugs Bypass Macroeconomic Headwinds - Ian Somaiya - Piper Jaffray & Co.
Ian Somaiya - Piper Jaffray & Co.
-
Big Pharma Moves Toward Orphan Drugs & Emerging Markets - Damien Conover - Morningstar, Inc.
Damien Conover - Morningstar, Inc.
-
Product Pipeline & Diversification Are Key In Pharma - Dr. Jon Lecroy, M.d. - Mkm Partners
Dr. Jon Lecroy, M.d. - Mkm Partners
-
Innovation Is Key Theme In Biotechnology - Ravi Mehrotra - Credit Suisse
Ravi Mehrotra - Credit Suisse
-
International Stem Cell Corporation - Kenneth C. Aldrich
Kenneth C. Aldrich
-
Marshall Edwards, Inc. - Daniel P. Gold
Daniel P. Gold
-
Acura Pharmaceuticals, Inc. - Robert B. Jones
Robert B. Jones
-
Tranzyme, Inc. - Vipin K. Garg, Ph.d.
Vipin K. Garg, Ph.d.










